Previous 10 | Next 10 |
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution Canada NewsWire BOSTON , LAUSANNE, Switzerland , and HIROSHIMA, Japan , Feb. 22, 2022 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with Hiroshima Uni...
Generation Investment Management’s 13F portfolio value increased from $24.05B to $24.33B this quarter. They increased Becton Dickinson, Clarivate, and Dentsply Sirona while reducing Alphabet, Thermo Fisher Scientific, Gartner, and Equifax. The top three positions are Baxter...
BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022. ...
Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS PR Newswire BOSTON and LAUSANNE, Switzerland and BORDEAUX, France and MARSEILLE, France , Feb. 1, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven ...
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer Canada NewsWire BOSTON and LAUSANNE, Switzerland, Jan. 26, 2022 /CNW/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that demo...
SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy a...
Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business Canada NewsWire BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /CNW/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform th...
BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40 th Annual J.P. Morgan Healthcare C...
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study Canada NewsWire Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and ...
SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Canada NewsWire Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS ...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...